This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Jie Chen: A Focus on C-FMS Kinase Inhibitors
Introduction
Jie Chen is an accomplished inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases. With a total of 4 patents to his name, Chen's work is paving the way for advancements in medical treatments.
Latest Patents
One of Jie Chen's notable inventions is related to substituted pyridine derivatives that serve as C-FMS kinase inhibitors. This invention encompasses pharmaceutical compositions containing these derivatives and their application in treating disorders mediated by c-fms kinase. The process for preparing these substituted pyridine derivatives is also a key aspect of his patent.
Career Highlights
Jie Chen is currently associated with Janssen Pharmaceutica NV, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic options that can improve patient outcomes.
Collaborations
Throughout his career, Jie Chen has collaborated with talented individuals such as Matthew Garrett Donahue and Heng-Keang Lim. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Jie Chen's contributions to the field of pharmaceuticals, particularly through his patents on C-FMS kinase inhibitors, highlight his role as a significant inventor. His ongoing work at Janssen Pharmaceutica NV continues to influence the development of new medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile